Hemostasis in the brain is of paramount importance because bleeding into the neural parenchyma can result in paralysis, coma, and death. Consistent with this sensitivity to hemorrhage, the brain contains large amounts of tissue factor (TF), the major cellular initiator of the coagulation protease cascades. However, to date, the cellular source for TF in the central nervous system has not been identified. In this study, analysis of murine brain sections by in situ hybridization demonstrated high levels of TF mRNA in cells that expressed glial fibrillary acidic protein, a specific marker for astrocytes. Furthermore, primary mouse astrocyte cultures and astrocyte cell lines from mouse, rat, and human constitutively expressed TF mRNA and functional protein. These data indicated that astrocytes are the primary source of TF in the central nervous system. We propose that astrocytes forming the glia limitans around the neural vasculature and deep to the meninges are intimately involved in controlling hemorrhage in the brain. Finally, we observed an increase in TF mRNA expression in the brains of scrapie-infected mice. This modulation of TF expression in the absence of hemorrhage suggested that TF may function in processes other than hemostasis by altering protease generation in normal and diseased brain. (J. Clin. Invest. 1993. 
Introduction
The brain must use efficient mechanisms to limit hemorrhage in the central nervous system (CNS)'. Intracranial hemor-rhage, whether resulting from cerebrovascular disease or acute brain trauma, can result in paralysis, coma, and death. Stroke is currently the third leading cause of death and the primary cause ofdisabilities in the Western hemisphere ( 1, 2) . Fibrinolysis of the occluding thrombus after a stroke leads to reperfusion of damaged hypoxic vessels and diffuse petechial bleeding into the parenchyma from the damaged microvasculature (reviewed in reference 3). This bleeding is often toxic to neuronal function, radically altering the unique neural microenvironment formed by the blood-brain barrier.
Tissue factor (TF), also known as tissue thromboplastin, is the primary cellular initiator of the coagulation protease cascades (reviewed in references [4] [5] [6] . Activation of these cascades results in the generation of thrombin, a pleiotropic agonist for cells bearing the thrombin receptor (reviewed in reference 7) , and ultimately in the deposition of fibrin. TF is a member ofthe cytokine/hematopoietic growth factor receptor family (8) and is constitutively expressed by extravascular cells, such as cells in the tunica adventitia surrounding major vessels and cells delimiting organ boundaries (9, 10) . When vascular integrity is disrupted, binding of plasma Factor VII/ VIIa to TF expressed on extravascular cells initiates the coagulation protease cascades by activating both Factors IX and X. Thus, TF plays a pivotal role in initiating blood coagulation. Consistent with this role for TF in hemostasis and the great sensitivity ofthe brain to hemorrhage, high levels ofTF mRNA and functional protein are found in the brain (1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] .
The TF gene exhibits a distinct pattern of tissue-specific expression in vivo and is inducible in a variety of cultured cell types. For example, it has been defined as an immediate-early gene in fibroblasts ( 11 ) and is induced in endothelial cells and cells of the monocyte lineage by inflammatory mediators (reviewed in reference 6) . These data suggest that TF may participate in processes other than hemostasis.
All studies analyzing human TF antigen expression by immunohistochemistry have observed a diffuse staining throughout the brain parenchyma (9, 10, 14) . Therefore, to date, it has not been possible to identify the cellular source of TF in the brain. In this study, we report the distribution of TF mRNApositive cells in the murine CNS using in situ hybridization.
Furthermore, we demonstrate that the signal for glial fibrillary acidic protein (GFAP), a marker for astrocytes in the CNS (reviewed in reference 15) , colocalizes with the hybridization signal for TF mRNA in the parenchyma, indicating that the TF mRNA-positive cells are astrocytes. These results suggest that astrocytes, in addition to their roles in neuronal support and blood-brain barrier formation, may be intimately involved in preventing hemorrhage within the CNS. Finally, we observed increased TF mRNA expression in scrapie-infected murine brains in the presence of an extensive reactive astrocytosis.
Methods
Animals. Adult, male SWR/j and C57BL/6j mice (breeding colony, The Scripps Research Institute) were used for all experiments. For infection with the Chandler strain of scrapie ( 16), 4-6-week-old mice were anesthetized with metafane by inhalation and then injected intracerebrally with 30-50 14 ofa 10% scrapie-infected mouse brain homogenate. Scrapie-infected mice for in situ hybridization and immunohistochemistry were killed at I I wk (preclinical), 16 wk (early clinical), and 21 wk (late clinical) after inoculation.
Tissue preparation. Mice were deeply anesthetized with 0.7g/kg body wt of chlorol hydrate injected intraperitoneally, then trans-cardially perfused with 4% paraformaldehyde in chilled PBS. The brains were removed and postfixed in the same solution at 40C overnight, before being dehydrated and embedded in paraffin. 3-,gm thick sections were cut using a rotary microtome, mounted onto "Superfrost plus" slides (Fisher Scientific Co., Pittsburgh, PA) and stored at room temperature before use.
Riboprobe preparation. The murine TF cDNA probe was an 821-bp fragment isolated from plasmid pcmTF2253 (17) . This fragment was subcloned into the vectors pGEM-3Z and pGEM-4Z (Promega Corp., Madison, WI) and used as a template for the in vitro transcription of radiolabeled sense (pGEM-3Z) and antisense (pGEM-4Z) TF riboprobes using SP6 polymerase (Promega) in the presence of 35S-UTP (> 1,200 Ci/mmol; Amersham Corp., Arlington Heights, IL). Templates were removed by digestion with RQ I DNAse (Promega) for 15 min at 37°C, and the riboprobes were purified by phenol/chloroform extraction and ethanol precipitation.
In situ hybridization. In situ hybridization was performed as previously described ( 18) . Briefly, paraffin-embedded tissue sections were pretreated sequentially with xylene (3 X 5 min), 2x SSC (300 mM NaCl, 30 mM sodium citrate, pH 7.0, containing 10 mM 2-mercaptoethanol, I mM EDTA) (1 X 10 min), paraformaldehyde (1 X 10 min 4C) and proteinase K (1 mg/ml in 500 mM NaCl, 10 mM Tris-HCl, pH 8.0) (1 X 10 min). (Note: all incubations and washes were performed at 25°C unless specified otherwise.) Slides were prehybridized for 2 h in 100 td of prehybridization buffer (50% [wt/vol] formamide, 0.3 M NaCl, 20 (20 yd) (containing 2.5 mg/ml oftRNA and 600,000 cpm ofthe 35S-labeled riboprobe) was then added, and the slides were hybridized for 18 h at 55°C. After hybridization, slides were treated with 2X SSC containing 10 mM 2-mercaptoethanol, 1 mM EDTA (2 X 10 min), RNAse A (20 mg/ml in 500 mM NaCl, lOmM Tris-HCI) (1 X 30 min), 2x SSC (10 mM 2-mercaptoethanol, 1 mM EDTA) (2 X 10 min), 0.1 x SSC (10 mM 2-mercaptoethanol, 1 mM EDTA) (1 X 2 h, 60°C) and O.5X SSC (2 X 10 min). Finally, after dehydration by immersion in a graded alcohol series containing 0.3 M NH4Ac, the slides were dried, coated with NTB2 emulsion (Kodak; 1:2 in water), and exposed in the dark at 4°C for 8-12 wk. Slides were developed for 2 min in Dl9 developer (Kodak), fixed, washed in water (3 X 5 min), and counterstained with hematoxylin and eosin. Serial sections were analyzed using a TF sense riboprobe as a control for nonspecific hybridization. No specific signal could be detected in these control hybridizations.
Immunohistochemistry. Sections were deparaffinized through a xylene and ethanol gradient, blocked in 5% normal calfserum in PBS for 30 min, then incubated overnight at 4°C in a humidity chamber with the primary antibody, rabbit anti-bovine GFAP (Dako Corp., Carpinteria, CA) diluted 1:400. Immunopositive cells were then visualized with the highly sensitive avidin biotin complex-horseradish peroxidase histochemistry procedure (Vector Laboratories, Burlingame, CA) according to the manufacturer's protocol, using a diaminobenzidine substrate (tetrahydrochloride salt; Sigma Immunochemicals, St. Louis, MO). For double labeling of the same tissue section, slides were initially subjected to in situ hybridization using a TF riboprobe. Slides were then removed from the O.5x SSC wash before alcohol dehydration and treated for immunohistochemistry. After GFAP staining, the in situ hybridization protocol was continued with dehydration of the slides and coating with emulsion. Immunofluorescence was carried out basically as above except that the avidin biotin complex-horseradish peroxidase reagents were replaced with a goat anti-rabbit FITC-conjugated antibody (Caltag Laboratories Inc., San Francisco, CA), diluted l:100. Controls were carried out in the absence of the primary antibody.
Tissue culture. Mouse primary astrocyte cultures were isolated from neonatal mice following the protocol of McCarthy and de Vellis ( 19) . Briefly, neonatal mice were decapitated and the brains removed, leaving as much of the meninges behind as possible. The brains were disaggregated, first with a pipette, then with an 18' gauge needle and placed in poly-L-lysine-coated flasks. After 2 d the flasks were rapped to remove loosely adherent cells, and then on day 5 shaken overnight to remove oligodendrocytes and microglia. By immunofluorescence, such cultures in our laboratory are > 95% GFAP positive. The murine JCT cell line arose by spontaneous immortalization of an astrocyte in primary culture in our laboratory and expresses GFAP and Sl00( protein by immunofluorescence, and glutamine synthetase mRNA by Northern blot, all markers ofastrocytes ( 15) (de la Torre, J. C., and M. Eddleston, unpublished data). The human glioblastoma U373 MG and grade IV astrocytoma CCF-STTGI cell lines were obtained from the American Type Culture Collection, Rockville, MD. The oligodendrocyte cell line 36C.2 1 was a gift from M. Carson and A. McMorris (Wistar, PA). The cell lines were kept at 370C in DMEM-high glucose medium supplemented with 10% heat-inactivated FCS, penicillin, streptomycin, and 1% glutamine, except for U373 MG and PC 12 cells, which had 1 mM sodium pyruvate or 5% horse serum added to the medium, respectively. The oligodendrocyte cell line 36C.2 1 was differentiated for 6 days in low serum ( 1% FCS) and 5 ug/ml insulin. PCl2 cells were differentiated to express a neuronal phenotype by treatment with 100 ng/ml 3 nerve growth factor for 72 hours (20) .
Northern blot analysis. Mice were killed by cervical dislocation and then the organs quickly removed and snap frozen in liquid nitrogen. Total RNA was isolated from mouse brains by the guanidinium isothiocyanate-phenol chloroform method (21 ) . PolyA+ RNA was then selected by a further cycle ofoligo (dT)-cellulose (Invitrogen, San Diego, CA) chromatography. 4 There was striking expression of TF mRNA in the cells of the leptomeninges (Fig. 1 A) . In areas where the arachnoid mater had been removed during tissue preparation, there was no signal associated with the remaining cells of the pia mater (data not shown), indicating that it was the arachnoid cells that expressed high levels of TF mRNA. As a control for specificity of the antisense TF riboprobe, serial sections were hybridized with a sense TF riboprobe but produced no specific signal (Fig. 1 B) .
A regular scattering of strongly hybridizing cells was observed throughout the brain parenchyma, particularly within the gray matter (Fig. 1 C) . Occasional TF mRNA-positive cells were also found within the white matter tracts, although the signal was less intense (Fig. 1 F) . This pattern of TF mRNA expression was consistent with a neuroglial distribution. Furthermore, the hybridizing cells of both gray and white matter exhibited relatively large gray nuclei, no distinct nucleoli, uncondensed chromatin, and apparently sparse cytoplasm surrounding the nucleus, all morphological features typical of astrocytes.
In the cerebral cortex, TF mRNA-positive cells, similar to those shown in Fig. 1 C, occurred in all six layers (data not shown). Cells expressing TF mRNA were also observed scattered throughout the striatum, hypothalamus and thalamus, midbrain, pons, and medulla (data not shown). TF mRNApositive cells were notably absent only from the molecular cell layer of the cerebellum, an area particularly rich in microglia (25) . In the hippocampal formation, a less intense but specific hybridization signal was observed in cells present in Ammon's horn and the dentate gyrus (Fig. 1 D) . In the olfactory lobe, TF mRNA-positive cells again occurred randomly but particularly within the external plexiform (Fig. 1 E) and internal granular layers. TF mRNA-positive cells exhibited a morphology and distribution consistent with that of astrocytes.
Cells cytologically identified as neurons were consistently negative for TF mRNA expression throughout the mouse brain using in situ hybridization (Fig. 1 ) . For example, in the hippocampal formation the pyramidal cells of CA 1-3 (data not shown), granular cells of the dentate gyrus (dg) and hilar neurons (hn) did not express detectable levels ofTF mRNA (Fig. 1  D) . In addition, Fig. 1 E shows that the mitral (m), tufted (t), periglomerular (pg), and internal granular (g) neurons of the olfactory lobe were all negative for TF mRNA expression, as were the Purkinje cells, granular cells, and neurons of the deep nuclei and molecular layer in the cerebellum (data not shown).
Oligodendrocytes, identified cytologically by their dark compact nuclei and arrangement in interfascicular rows (26) , within the corpus callosum (Fig. 1 F) , anterior commissure, cerebellar peduncles, and Vth cranial nerve tract of the medulla did not express detectable levels of TF mRNA.
The endothelial cells of parenchymal blood vessels were consistently negative (Fig. 1 G) , as were cells aligned with the vessels. In addition, no expression was observed in cells of vessels present within either the sub-arachnoid space or the choroid plexus (Fig. 1 H) . The ependymal cells lining the ventricles (Fig. 1 F) , and the epithelial cells of the choroid plexus ( Fig. 1 H) were negative. However, strongly positive cells were seen in the choroid plexus's core of connective tissue ( Fig. 1  H) ; these cells had dark, compact nuclei suggestive of fibroblasts which are known to be present in the connective tissue stroma (27) .
Astrocyte TF expression in vitro. Our studies described above suggested that astrocytes in vivo express relatively high levels ofTF mRNA. To extend these observations, we analyzed TF expression in a variety of neural cells from three species. Initial northern blot analysis indicated that a mouse astrocyte cell line, termed JCT (Fig. 2) , and mouse primary astrocyte cultures (data not shown) both constitutively expressed high levels of the 1.8-kb TF transcript. TF mRNA expression was then examined in human and rat astrocyte cell lines to determine if TF expression was a general feature of cultured astrocytes. Two human astrocyte cell lines (AST-U373 and AST-CCF) and one rat glioma cell line (AST-C6) also produced high levels of TF mRNA (Fig. 2) , indicating that cultured astrocytes of three species constitutively expressed TF mRNA.
In addition to these studies on astrocytes, we assessed the level of TF mRNA expression in other cultured CNS cell types. GT1-7 cells, a murine hypothalamic neuronal cell line (28), expressed TF mRNA, although the level was significantly lower than that of JCT astrocytes. The rat oligodendrocyte cell line, 36C.2 1, expressed TF mRNA, but again at levels lower than the rat C6 astrocytes. Lastly, the pheochromocytoma cell line, PC 12, both undifferentiated and differentiated with jNGF to produce a neuronal phenotype (20) , failed to express detectable levels of TF mRNA. Total RNA from both murine brain and kidney were used as positive controls because these tissues express high levels of the 1.8-kb TF mRNA (29) . Murine B cells were used as a negative control and, as expected, did not express the TF transcript.
After our observations that cultured astrocytes express TF mRNA, we sought to determine whether astrocytes produced a functional procoagulant protein. Because it is not possible to identify the cellular source of functional protein in whole brain extracts, the total cellular TF protein levels of murine JCT and human U373 astrocyte cells were analyzed using a singlestage clotting assay. JCT cells constitutively expressed high lev- (Fig. 3) , reflecting the extensive astrocytosis following infection. Nevertheless, we found no evidence for increased numbers of astrocytes in infected brains. GFAP-expressing astrocytes from both control and infected brains were TF mRNA-positive on serial sections (Fig. 3) ; however, some TF mRNA-positive cells were observed in both control and infected brains that did not stain for GFAP. Double-labeling on serial sections has limitations because cells on one section may not be present on the next section. In addition, the observed GFAP-negative, TF mRNA-positive cells may be astrocytes that are expressing GFAP below the detection threshold of the immunohistochemistry technique. This explanation is more likely in control brains which do not exhibit astrocytosis. The glia limitans, which forms the boundary between brain and meninges, stained strongly with GFAP but exhibited no hybridization to the antisense TF riboprobe because it contains few astrocyte cell bodies (Fig. 3, A and B) .
The hybridization signal associated with cells in scrapie-infected brain sections appeared to be consistently more intense than the signal associated with astrocytes in uninfected brain sections present on the same slide. data revealed an increase in TF mRNA-expression in astrocytes after infection. Similar results were observed in three independent experiments. TF mRNA expressing cells were also more prevalent in the white matter tracts in scrapie-infected brains (data not shown). These results suggested that TF mRNA expression in astrocytes may be upregulated during scrapie infection. Due to the inherent problems associated with using serial sections to identify the TF mRNA-positive cell population, in situ hybridization for TF and immunohistochemistry for GFAP were performed on the same sections ofscrapie-infected mouse brain. The great majority of GFAP-positive cells expressed high levels ofTF mRNA (Fig. 4, A-D) , and no specific hybridization signal was associated with nonastrocytes in the parenchyma. Thus, within the detection limits of the in situ hybridization assay, astrocytes were the only cell type to express TF mRNA within the parenchyma of scrapie-infected brains. Strongly TF mRNA-expressing cells of the arachnoid mater were clearly identified (Fig. 4, E and F) whereas cells directly in contact with the glia limitans were negative.
To quantitate more accurately this apparent increase in TF mRNA expression during reactive astrocytosis, TF mRNA levels were compared by Northern blot analysis using RNA derived from scrapie-infected and uninfected mouse brains.
PolyA' RNA was isolated from the brains of either scrapie-infected mice exhibiting clinical symptoms of gait disturbances, kyphosis, and somnolence (34), or uninfected age-matched control mice. The RNA was resolved by gel electrophoresis and the resulting Northern blots hybridized with a GFAP cDNA probe to assess the astrocytosis in the diseased brains. GFAP mRNA levels, indicative of an activation of astrocytes, were markedly increased in infected brains (Fig. 5) . The blots were subsequently hybridized with a murine TF cDNA fragment which revealed that the level of TF mRNA was increased in scrapie-infected brains compared to uninfected controls (Fig.  5) . The TF mRNA signal was quantitated by densitometry scanning and normalized usingglyceraldehyde-3-phosphate dehydrogenase to control for RNA loading. Comparison of six control brains and six scrapie-infected brains in two independent experiments indicated that TF mRNA levels were increased 3.2-fold (SD = 1.45) in infected brains. Using the Student's t test, this increase is statistically significant (0.01 > P > 0.001). Thus, TF mRNA levels in the brain can be modulated in vivo by scrapie infection.
Discussion
In this study, the colocalization of murine TF mRNA expression and GFAP indicated that TF biosynthesis in the neural astrocyte in the cerebellum, express high levels ofTF mRNA in the murine brain (29) .
Arachnoid meningeal cells surrounding the brain expressed high levels ofTF mRNA while identifiable neurons and nonastrocyte glial cells did not express TF mRNA in the parenchyma at levels detectable by in situ hybridization (Figs. 1 and 4) . We found no evidence for TF mRNA expression by microglia. The lack of detectable TF mRNA in specific neuronal cell populations correlated with the absence of human TF antigen in Purkinje and granular neurons by immunohistochemistry (10) . However, previous studies using anti-human TF antibodies have reported a diffuse TF antigen expression throughout the parenchyma (9, 10, 14) . This may suggest that nonastrocyte cells of the brain also express TF but at levels below the detection threshold of in situ hybridization. This hypothesis is consistent with the low level of TF mRNA expression we observed in nonastrocyte cell lines in vitro (Fig. 2) .
TF expression in astrocyte endfeet (see Fig. 6 below) may explain the earlier reported strong expression of TF antigen surrounding major ( 14) and micro (35) CNS vessels and deep to the pia mater in the parenchyma (9) . In addition, TF mRNA expression by cells ofthe arachnoid mater is consistent with previous immunohistochemical localization of TF in the leptomeninges of human brain (10) . In contrast, the cells of the pia mater, which form the adventitia of large blood vessels in the CNS (36), did not express detectable levels of TF mRNA. TF expression by fibroblast-like cells in the stroma of the choroid plexus has been observed using anti-human TF monoclonal antibodies (T. Drake, personal communication), consistent with our data. The greater expression of TF mRNA by cells in the gray matter relative to white matter observed in our study agrees with the reported distribution of neural TF protein by immunohistochemistry, ELISA, and functional assays (9, 10, 35) .
Astrocytes constitute a substantial proportion of the CNS, participating in a number of important physiological processes. In the developing brain, cells of the astrocyte lineage are believed to form a scaffold along which neurons migrate to find their position in the neural cytostructure. In the adult brain, astrocytes buffer neurons from changes in ion and toxic neurotransmitter concentrations, supply trophic support to neurons and other neural cells (reviewed in references [37] [38] [39] , and may play an important role in signaling (reviewed in reference 38). Roles for astrocytes in the induction ofthe blood-brain barrier (40) and control of the microvascular blood flow in the brain (38) have also been proposed. Here, we provide new evidence that astrocytes also function in the control ofhemostasis at the blood/CNS interface by expressing tissue factor.
The observed distribution of TF expression in astrocytes and arachnoid meningeal cells is consistent with a primary role for TF in CNS hemostasis. The meninges cover the surface of the brain, separating the brain parenchyma from peripheral tissues. The basement membrane of the innermost pia mater layer of the meninges lies directly in contact with the glia limitans, a boundary formed by astrocyte endfeet (Fig. 6, A, B , and D). These endfeet are extensions of the termini of astrocyte processes extending from the cell bodies which may lie at some distance in the parenchyma (Fig. 6 B) . As blood vessels pass from the subarachnoid space into the neural parenchyma, they are ensheathed within the glia limitans, which continues to surround every blood vessel within the brain (Fig. 6 , Cand E), from arteries through capillaries to veins (see reference 36 for a detailed description). Expression of TF in arachnoid meningeal cells and astrocyte endfeet processes would result in the complete ensheathment of the interface between the CNS and cerebrospinal fluid/blood by cells that express TF, thus forming a "hemostatic envelope" around the CNS. In the periphery, in contrast, TF expression is predominantly restricted to the tunica adventitia of the major vessels and myoepithelial sheathes surrounding each organ (9, 10) .
The extensive expression ofTF may reflect the sensitivity of the brain to hemorrhage and the potential consequences to the organism ofdysregulated neuronal function. Studies have suggested that neuronal dysfunction and seizure activity after hemorrhagic injury is related to the induction of free radicals by iron moieties released from extravasated blood, and the subsequent peroxidation of lipids (reviewed in references 41, 42) . A high level of TF expression around the neural blood vessels might also have damaging consequences for the organism during disease or injury. In particular, exposure of high levels of TF protein from the CNS after damage to neural blood vessels could account for the transient disseminated intravascular coagulation seen following acute, severe brain trauma (43, 44) .
In addition to its role in hemostasis, TF may function in other processes within the CNS. In this study, we found that TF mRNA levels were increased 3.2-fold in scrapie-infected mouse brains in the presence ofan extensive reactive astrocytosis. It is of note that astrocytes were the only cell type observed to express TF mRNA in double labeling experiments of scrapie-infected brains. We speculate that increased TF expression in astrocytes may account, in part, for the increase in total brain TF mRNA after infection, although an increase in TF expression below the detectable threshold of in situ hybridization in cell types other than astrocytes cannot be discounted. The absence of vascular damage during scrapie infection supports the possibility that TF is fulfilling functions in the CNS other than the control ofhemorrhage during the reactive astrocyte response. Consistent with other roles for this transmembrane receptor in neurobiology, TF is highly expressed in peripheral nerves (10) and in the supporting cells of autonomic ganglia (9, 10) . TF may be involved in the interaction between neurons and their supporting cells, either directly through binding to another receptor, or indirectly through the generation of proteases such as thrombin (7) . The recent evidence that coagulation proteases may be involved in the pathogenesis of human diseases such as Alzheimer's disease (reviewed in reference 45) , suggests that it will be important to understand the roles of TF in the CNS.
